2023-03-20 07:13:52 ET
- Exelixis ( NASDAQ: EXEL ) has authorized $550M share repurchase program of the company’s common stock before the end of 2023.
- The timing and amount of any share repurchases under the share repurchase program will be based on an ongoing assessments of the capital needs of the business, alternative investment opportunities, the market price of the common stock and general market conditions.
- The program does not obligate the company to acquire any particular amount of its common stock, and the share repurchase program may be modified, suspended or discontinued at any time without prior notice.
- Shares have gained around 7% since the start of 2023.
- A quick look at the company's ownership structure:
For further details see:
Exelixis approves $550M share repurchase program